Medindia

X

Paras Pharma Attracts Global Drug Majors

by Rathi Manohar on  October 13, 2010 at 10:43 PM Drug News   - G J E 4
Indian drug-maker Paras Pharma has attracted bids for a majority stake from several global pharmaceutical majors, disclosed a report.
 Paras Pharma Attracts Global Drug Majors
Paras Pharma Attracts Global Drug Majors
Advertisement

British giant GlaxoSmithKline, France's Sanofi-Aventis, Swiss multinational Novartis, and US-based Johnson and Johnson have all made bids for the over-the-counter drug major, the Business Standard said, citing sources close to the bidding process.

Advertisement
The initial bids ranged between the 600 and 700 million-dollar mark, one source told the newspaper, undershooting the expected valuation of close to one billion dollars.

"Serious players such as Japan's Taisho Pharmaceuticals are expected to join the race," one of the sources added.

Paras owns popular brands in the Indian market like anti-cold medication D'Cold and pain-relieving ointment Moov.

A Novartis spokesman contacted by AFP refused to comment on the report.

Source: AFP
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All